Many studies have shown overexpression of PBK/TOPK in malignancies such as Ewing sarcoma, lymphoma, leukemia, melanoma, breast cancer, lung cancer, cholangiocarcinoma, and CRC [13–16]. This evidence concerns the gene PBK and breast carcinoma.